Press Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Mar 21, 2023 Evofem Biosciences Announces Cost Reduction Measures Mar 9, 2023 Evofem Biosciences Appoints Interim Chief Financial Officer Feb 28, 2023 Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering Feb 27, 2023 Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi Feb 23, 2023 Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value Jan 12, 2023 Evofem's Phexxi Contraceptive Gel to be Offered by Female Telehealth Leader Favor (Formerly The Pill Club) Photos 1 Jan 10, 2023 Costco Adds Phexxi® to Member Prescription Program Jan 9, 2023 Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of Women Dec 29, 2022 OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022 Oct 11, 2022 Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women Show 5102550100 per page«123456789…21»
